ABSTRACT-There have been several reports concerning the therapeutic effect of an extract from animal prostates on benign prostatic hypertrophy. Previously, we re ported that the swine prostate extract (PE) had the activity to enhance human prosta tic acid phosphatase (PAPase) activity in vitro, and to increase the muscular tonicity of the urinary bladder by directly acting upon vesical muscles, suggesting that PE have an activity to elevate the intravesical voiding pressure in vivo. In the present study, it was attempted to isolate such an active principle of PE as activates human prostatic acid phosphatase (PAPase). The finally purified PE (PPE) was assessed as to some physico-chemical and pharmacological properties. 1) PPE was found to be a peptide with a molecular weight of about 8,800, composed largely of neutral amino acids (approximately 70%) and few of aromatic amino acids. 2) PPE activated PAPase in a dose-dependent fashion, resulting in an increase of the enzyme activity approximately twice in a dose of 2 X 105 g/ml of PPE. Furthermore, PPE recovered PAPase activ ity dose-dependently from the 50% inhibition by 2 X 10-3 M L-tartaric acid. 3) In castrated rats, the 3H-testosterone uptake of the prostate was significantly suppressed by the oral administration of PPE. PPE might be one of active principles of PE for the therapeutic effect on prostatic hypertrophy.
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While it is widely accepted that prosta tectomy is most effective for the treatment of prostatic hypertrophy, patients suffering from this disease are usually elderly and reluc tant to undergo surgical treatment. The major ity of the patients are in the early stages of this disease. In such stages of the disease, the operative ectomy is not necessarily required, and conservative treatment is adequate in so far as it eliminates renal impairments and complaints due to the disturbance of urina tion.
There have been several reports (1-4) con cerning the effectiveness of an extract from animal prostate on prostatic hypertrophy. Pre viously, we reported (5-7) that the swine prostate extract (PE), which was prepared by a method devised in our laboratory, enhanced human prostatic acid phosphatase (PAPase) activity in vitro and increased the muscular tonicity of the urinary bladder by directly acting upon vesical muscles, suggesting that the extracts have an activity to elevate the in travesical voiding pressure in vivo.
It was reported that PAPase activity was dependent on androgen (8, 9) ; it showed its peak at around 25 years of age when the physiological function of the prostate became most active, and then the activity decreased with aging (10) . It is likely that PAPase plays some role in the physiological function of the prostate, although it is unclear whether PAPase participates in the development of prostatic hypertrophy.
In the present paper, we have tried to iso late and purify the PAPase activating subst ance from PE to examine the effect of the substance on the prostate. There is a possibil ity that the purified PE (PPE) obtained here is one of the active principles of PE involved in the therapeutic effect on prostatic hypertro phy. PPE may be useful for examining the physiological role of PAPase in the prostate. In this report, we assessed some of the physi cochemical and pharmacological properties of PPE.
MATERIALS AND METHODS

Materials
The prostate extract (PE) subjected to puri fication was prepared by previously described procedures (5) . Briefly, the homogenate of swine prostate (15%) was adjusted to pH 1.5 with 6 N HCl and hydrolyzed by stirring it for 72 hr at 75°C. The hydrolysate was neutralized with 6 N NaOH and then added with m-cresol in a final concentration of 0.3%. The hydroly sate was filtrated by suction through a paper filter (PAD No. 85, Toyo Roshi Co., Ltd.). The yield of PE was 4.5 g from 100 g of the prostate. Other materials used in this study in cluded: Sephadex G-15 and Sephadex G-25 superfine (Pharmacia Fine Chemicals); cellu lose powder (Merck); Dowex 50Wx8 (Dow Chemicals); nitrophenyl phosphate, sodium dodecyl sulfate (SDS), dansyl chloride, N,N,N',N'-tetramethylethylenediamine, urea, vitamin B12, testosterone propionate, acetic anhydride and pyridine (Nacalai Tesque); acryl amide (Komune Chemicals); bis methylene acryl amide (Tokyo Kasei); cytochrome C and insulin (Sigma); 5'-adeno sine monophosphate (5'-AMP, Kohjin); and { 1 a ,2a -3H(N) 1-testosterone (3H-testosterone, specific radioactivity: 57.0 Ci/mmol; New Eng land Nuclear). Human prostatic acid phosphat ase (PAPase) was a fraction of peak II obtained by the method of Saito (11); it was dispensed and frozen in aliquots of a few mil liliters in vials for storage. Each aliquot was thawed and diluted 250 to 300-fold with water before use.
Animals
Eighteen-week-old male rats of the Wistar strain were purchased from Kitayama Labs. The animals were used for the experiment af ter an acclimatization period of more than 7 days. They were housed in cages in an air-con ditioned animal room at 22 ± 2°C with 55 ± 5% relative humidity and supplied with water and solid feed ad libitum.
SDS disc electrophoresis
Dansylated PPE mixed with dansyl chloride as a tracking marker was subjected to SDS disc electrophoresis. The sample specimen was electrophoresed on a 2.5% acrylamide gel added with 0.1% SDS. Electrophoresis was carried out at a constant current of 2.5 mA per polyacrylamide gel in a 5 X 90 mm col umn, using 0.1 M tris acetate buffer (pH 8.2). The fluorescence of the marker, dansyl-OH, was monitored with a UV monitor (Manaslu lamp) at 360 nm during the 6 hr of elec trophoresis.
Estimation of molecular weight
The molecular weight of PPE was estimated by gel filtration chromatography with Sephadex G-25 superfine (18 X 340 mm) and by calculating the ratio of elution volume (Ve) to the total bed volume (Vb), Ve/Vb. Cytochrome C (MW 12,600), insulin (MW 5,733), vitamin B12 (MW 1,355) and 5'-AMP (MW 347) were used as molecular-weight mark ers. For detection of PPE and the molecular weight markers, infrared and ultraviolet absorption spectrometries were performed by the usual procedures.
Amino acid analysis
One to 3 mg of sample was dissolved in 3.0 ml of 6 N HCl solution, sealed in a hard glass hydrolysis tube under reduced pressure, and heated at 110°C for 48 hr. The hydrolyzed and dried material was then dissolved in 1.0 ml of water and 0.4 to 0.5 ml of the solution was subjected to analysis on a Hitachi KLA-3 Amino Acid Autoanalyzer. Hitachi Spherical Resin No. 3105 was used in a 9 X 550-mm col umn (resin height: 480 mm) equilibrated with citrate buffers of pH 3.25 and 4.25 for neutral and acid substances, respectively, and in a 9 X 150-mm column (resin height: 95 mm) equilibrated with a citrate buffer of pH 5.28 for basic substances.
Effect of PPE on PAPase activity
The effect of PPE on PAPase activity was assessed using the Bessey-Lowry method (12) . To 1.0 ml of substrate buffer (mixture of equal volumes of 0.4% disodium p-nitrophenyl phos phate solution and 0.2 M citrate buffer, pH 4.8), 0.1 ml of the test sample solution was added and pre-warmed at 37°C for 5 min. Then, 0.1 ml of PAPase was added to the mix ture and incubated at 37°C for 30 min. After termination of the reaction by adding 4.0 ml of 0.1 N NaOH solution, the absorbance at 410 nm was determined against a blank in which PAPase was added after the stop solu tion. Results were expressed as percent to the OD value of the reaction mixture without PPE.
Effect of PPE on testosterone uptake in cas trated rat prostate Two groups of 5 male rats were injected with testosterone propionate, s.c. into their buttocks in a dose of 0.5 mg/kg on days 8, 10, 12 and 14 after bilateral orchi-ectomy under anesthesia with ether. On day 15, the animals were given 50,uCi of 3H-testosterone, i.p. Blood was drawn, and the ventral lobe of the prostate was removed 2 hr after the injection to measure the radioactivity. PPE was given to one group of rats p.o. in a dose of 3 mg/kg/day, daily, for 7 days beginning on day 8 after the castration. The other group, serv ing as the control, received the equal volume of water, the vehicle. The ventral lobe of the prostate removed from each rat was placed in a glass liquid scintillation vial, and then it was solubilized by incubation with 0.5 ml of NCS solubilizer (Amersham/Searle) per 100 mg of the tissue for 4 hr at 40°C, followed by 24 hr at room temperature. The determined radioac tivity was expressed as DPM/tissue/100 g body weight. The radioactivity in the serum was measured by essentially the same procedure as described above, but the specimen was incu bated with NCS solubilizer at 40°C for 20 min for complete solubilization. The result was ex pressed as DPM/0.1 ml serum.
Statistical analysis
Data were statistically evaluated using Stu dent's t-test.
RESULTS
Isolation of active principle from PE
The isolation procedure for the active prin ciple from PE is shown in Fig. 1 . The PE sam ple was extracted with absolute methanol, and the soluble portion (Fr-A) was evaporated to dryness. Then, Fr-A was extracted with abso lute ethanol. The ethanol-soluble portion and insoluble portion were defined as Fr-B and Fr C, respectively. Since PAPase activating activ ity was recovered in Fr-C, this fraction was subjected to Sephadex G-15 gel filtration (Fig.  2) . The PAPase activating activity was recov ered in the eluate corresponding to 0.34-0.60 Ve/Vb (Fr-D). Fr-D was then subjected to ion-exchange chromatography on Dowex 50Wx8 by stepwise elution using five different solvents: 0.01 M ammonium formate buffer (pH 2.49, Fr-D1), 0.1 M ammonium acetate buffer (pH 5.50, Fr-D2), 0.2 M ammonium acetate buffer (pH 6.88, Fr-D3), 0.1 N ammo nium solution (Fr-D4) and 1.0 N ammonium solution (Fr-D5), in this order. PAPase acti vating activity was detected in three fractions, Fr-D2, Fr-D3 and Fr-D4. Fr-D3 that had the highest activity among them was re-chroma The column (70 X 700 mm) was operated using water as a solvent with a flow rate of 50 ml/hr, and 15-ml fractions were collected. The fractions were monitored for absorbance at 276 nm and activation of human prostatic acid phosphatase (PAPase) activity.
tographed on Sephadex G-15 gel using a sol vent of 0.1 N acetic acid. Three peaks of absorbance at 276 nm were found in the elu tion pattern, and PAPase activating activity was found in the first peak (Fr-D3G). A 150 mg sample of Fr-D3G and 1 g of cellulose powder were added to a 20-m1 mixture of n butanol, acetic acid and water (4 : 1 : 5), and the suspension was evaporated to dryness. The dried material was packed in a chromato graphic column and washed with the mixture mentioned above and then eluted with water. The water eluate showing the highest PAPase activating activity was designated as fraction E4 (Fr-E4). Gel filtration of Fr-E4 using a col um of Sephadex G-25 superfine and 0.2 N ace tic acid solution as an eluent yielded two dis tinctive peaks with absorbance at.276 nm (Fig.  3) . The PAPase activating activity was in the region of 0.4 Ve/Vb. Acetic acid in the frac tion was removed by several repeated cycles of dissolving it in water and evaporating. This final fraction was used as purified PE (PPE) in the following experiments. The yield of PPE was 0.6 g from 100 g of PE.
SDS-disc electrophoresis SDS-disc electrophoretic analysis of dansy lated PPE is shown in Fig. 4 . The fluorescent band (yellowish green) at the front was dansyl-OH, and the band (orange) located close to the starting point was dansyl-tris. PPE showed a yellowish-green fluorescent between the two bands. The ratio of the distance traveled by PPE to that traveled by dansyl OH was approximately 0.3.
Estimation of molecular weight
The molecular weight of PPE was estimated by gel filtration on Sephadex G-25 superfine (Fig. 5) . The Ve/Vb of PPE was approximate ly 0.4, and the values of the marker com pounds, cytochrome C, insulin, vitamin B12 and 5'-AMP, were 0.34, 0.41, 0.58 and 0.70, respectively. From these data, the molecular weight of PPE was estimated to be 8,000 9,000. 6 . The IR spectrum of purified prostate extract (PPE). The IR absorption spectrum of PPE was deter mined using KBr tablets containing about 600,ug of PPE.
Infrared absorption spectrum
The IR absorption spectrum of PPE was de termined with a KBr tablet containing 600,ug of PPE on a Hitachi EPI-G3 Infrared Spectrom eter (Fig. 6) . Absorption bands at 1,650, 1,550 and 1,260 cm -1 were considered to be due to amido I (C = 0 stretching), amido II (N-H de formation and C-N stretching) and amido III (C-N stretching) vibrations, respectively. There was no band for an aromatic amino acid. Table 1 . Amino acid composition of purified prostate extract (PPE)
Amino acid analysis Effect of PPE on PAPase activity Figure 7 shows the effect of PPE (10-6 to 10-4 g/ml) on the activity of PAPase. PPE in creased the PAPase activity dose-dependently; PPE at a concentration of 2 X 10-5 g/ml caused an approximately two-fold increase in the PAPase activity. To investigate the mechanism of action, the Lineweaver-Burk re ciprocal plot of data was utilized (Fig. 8) . The values estimated from the graphic analysis were as follows: Vmax = 2.6,umole/,ug protein/min and Km = 286,uM in the absence of PPE and Vmax = 5.0 u mole/,u g protein/min and Km = 248 u M in the presence of PPE. Thus, the Km value did not differ virtually be tween the presence and absence of PPE, and the Vmax value showed an approximately two fold increase in the presence of PPE.
L-Tartaric acid is known to inhibit PAPase specifically (12) . The 50% inhibitory concen tration of L-tartaric acid on the enzyme activ ity was determined as 2 X 10-3 M. The kine tic parameters obtained from Lineweaver Burk reciprocal plots of the data ( Effect of PPE on testosterone uptake in cas trated rat prostate The serum level of 3H-testosterone of ani mals given PPE p.o. was almost the same as that of the control, whereas the amount of 3H testosterone in the ventral lobe of the prostate of the PPE-treated rats was significantly lower than that of the control group, thus indicating PPE suppressed the testosterone uptake of prostates in the castrated rats (Table 2) . Table 2 . Effect of purified prostate extract (PPE) on testosterone uptake of prostates in castrated rats DISCUSSION The PAPase activating substance was iso lated from PE. After the final purification step, the activity migrated as a single band in SDS-disc gel electrophoresis. The molecular weight of PPE was between 8,000 and 9,000 in the analysis by column chromatography, which was approximately the same as the calculated value, 8,835, from amino acid analysis. UV and IR spectral analyses revealed that the PPE molecule contained few aromatic amino acids, and this finding was consistent with the results of amino acid analysis of the substance. These findings indicated that PPE was a highly pure substance, being a peptide composed largely of neutral amino acids, including about 60% glycine, and it contained no cysteine.
PPE activated human PAPase activity dese dependently; PPE increased the Vmax value of the enzyme without affecting its Km value. PAPase was inhibited competitively in the presence of L-tartaric acid. PPE also dose-de pendently activated the PAPase activity in the presence of L-tartaric acid. These findings sug gest that PPE did not affect the affinity of the enzyme to the substrate, but accelerated the release of the product from the enzyme-sub strate complex. However, further studies must be performed to determine the details of the activation mechanism.
There have been several reports (1-4) con cerning the effectiveness of extracts from animal prostates on prostatic hypertrophy. In these cases, the extracts were administered via a parenteral route. Prostatic hypertrophy is a chronic disease, requiring long-term medica tion. Therefore, it is desirable to medicate such drugs through the oral route rather than parenteral routes. As shown in the present study, testosterone uptake into the prostate was reduced by the oral administration of PPE. Currently, excessive accumulation of tes tosterone or dihydrotestosterone in the pros tate is widely thought to be one of the major pathogenetic causes of benign prostatic hyper trophy. Shida et al. (13) 
